The Journal of Urology
Volume 183, Issue 4 , Pages 1598-1603 , April 2010

Screening Agents for Preventive Efficacy in a Bladder Cancer Model: Study Design, End Points, and Gefitinib and Naproxen Efficacy

Received 26 May 2009

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study received institutional animal care and use committee approval.

 Supported by National Cancer Institute Contract HHSN261200433001C.

PII: S0022-5347(09)03145-0

doi: 10.1016/j.juro.2009.12.001

The Journal of Urology
Volume 183, Issue 4 , Pages 1598-1603 , April 2010

Article Tools

* Image Usage & Resolution